Also trades as: KSPHF (OTC) · $vol 0M

¥3,700.00 ($23.44)

-130.00 (-3.39%)

Weekly Expected Move ±2.9%

¥3488 ¥3594 ¥3700 ¥3806 ¥3912

JPX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 33 · ¥153.4B mcap · 24M float · 0.392% daily turnover

Revenue

$97.4B +10.3% ▲

5Y CAGR: +7.1%

Gross Profit

$45.8B +4.0% ▲

5Y CAGR: +7.0%

Operating Income

-$2.9B -150.7% ▼

Net Income

$13.8B +15.2% ▲

5Y CAGR: +21.1%

EPS (Diluted)

$331.53 +20.9% ▲

5Y CAGR: +24.0%

EBITDA

$21.6B +6.5% ▲

5Y CAGR: +15.2%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$65.4B	$67.5B	$75.6B	$88.3B	$97.4B
YoY Growth	-5.3%	+3.2%	+12.0%	+16.9%	+10.3%
Cost of Revenue	$34.1B	$35.1B	$38.2B	$44.3B	$51.6B
Gross Profit	$31.2B	$32.4B	$37.3B	$44.1B	$45.8B
Gross Margin	47.8%	48.0%	49.4%	49.9%	47.0%
R&D Expenses	$10.4B	$10.4B	$9.5B	$12.9B	$0
SG&A Expenses	$19.9B	$20.3B	$20.8B	$22.2B	$48.7B
Operating Expenses	$32.6B	$33.5B	$33.3B	$38.3B	$48.7B
Operating Income	-$1.4B	-$1.1B	$4.0B	$5.8B	-$2.9B
Operating Margin	-2.1%	-1.7%	5.3%	6.5%	-3.0%
Interest Expense	$23M	$20M	$18M	$21M	$28M
Income Before Tax	$16.5B	$13.7B	$14.4B	$15.6B	$16.9B
Tax Expense	$3.5B	$3.0B	$3.2B	$3.6B	$2.9B
Net Income	$12.9B	$10.5B	$11.2B	$12.0B	$13.8B
Net Margin	19.8%	15.6%	14.8%	13.5%	14.1%
EPS (Diluted)	$280.19	$228.30	$246.58	$274.20	$331.53
EBITDA	$20.3B	$17.8B	$18.7B	$20.2B	$21.6B
Shares Outstanding	46M	46M	45M	44M	42M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$21.2B	$21.3B	$23.2B	$22.7B	$22.2B	$23.6B	$26.8B	$24.8B
Cost of Revenue	$10.3B	$10.8B	$11.5B	$11.7B	$11.1B	$12.0B	$14.5B	$13.9B
Gross Profit	$10.9B	$10.5B	$11.7B	$10.9B	$11.1B	$11.6B	$12.3B	$10.8B
Gross Margin	51.4%	49.4%	50.5%	48.3%	49.9%	49.1%	45.9%	43.7%
R&D Expenses	$2.6B	$4.5B	$0	$0	$0	$0	$0	$0
SG&A Expenses	$6.1B	$6.4B	$9.3B	$6.7B	$9.0B	$20.6B	$9.1B	$10.1B
Operating Expenses	$8.7B	$10.9B	$9.3B	$9.4B	$9.0B	$20.6B	$9.1B	$10.1B
Operating Income	$2.2B	-$376M	$2.5B	$1.5B	$2.1B	-$8.9B	$3.2B	$756M
Operating Margin	10.2%	-1.8%	10.6%	6.8%	9.5%	-37.8%	11.8%	3.1%
Interest Expense	$4M	$5M	$6M	$6M	$6M	$7M	$7M	$8M
Income Before Tax	$5.5B	$1.6B	$4.4B	$4.0B	$5.7B	$3.7B	$4.2B	$3.3B
Tax Expense	$1.4B	$490M	$811M	$916M	$1.2B	$305M	$915M	$482M
Net Income	$4.1B	$1.1B	$3.6B	$3.1B	$4.5B	$3.3B	$3.2B	$2.8B
Net Margin	19.4%	5.4%	15.5%	13.8%	20.4%	13.8%	12.1%	11.2%
EPS (Diluted)	$92.88	$25.83	$82.99	$72.91	$107.87	$78.77	$77.92	$66.76
EBITDA	$6.6B	$2.8B	$5.5B	$5.2B	$6.9B	$4.8B	$5.4B	$4.5B
Shares Outstanding	44M	44M	43M	43M	42M	41M	41M	41M

4547.T JPX